Trailing-twelve-month (TTM) revenue is N/A with a year-over-year growth of (41.88%). Revenue represents the total income generated from the company's primary business operations.
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2025 (2025-12-31): $9.87M.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2018-12-31 · HKD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · HKD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20132013-12-31 · HKD | FY20142014-12-31 · HKD | FY20152015-12-31 · HKD | FY20162016-12-31 · HKD | FY20172017-12-31 · HKD | FY20182018-12-31 · HKD |
|---|---|---|---|---|---|---|
| Disputes Forensics And Legal Technology | N/A | N/A | N/A | HKD 316M | HKD 305M | N/A |
| Disputes Investigations Economics | HKD 302M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · HKD | FY20182018-12-31 · HKD | FY20232023-12-31 · HKD | FY20242024-12-31 · HKD | FY20252025-12-31 · HKD |
|---|---|---|---|---|---|
| All Other | HKD 50M | N/A | N/A | N/A | N/A |
| Other Member | N/A | N/A | HKD 3M | HKD 24M | HKD 21M |
N/A
N/A
(41.88%)
(5.62%)
5 Year compound annual growth rate
1 Year
(41.88%)
3 Year
(26.54%)
5 Year
(5.62%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.63M | ($12.69M) | (41.86%) |
| 2024 | $30.33M | +$8.02M | +35.97% |
| 2023 | $22.30M | ($22.17M) | (49.85%) |
| 2022 | $44.48M | +$13.63M | +44.20% |
| 2021 | $30.84M | +$7.30M | +31.01% |
TTM Growth
(41.88%)
3-Year CAGR
(26.54%)
5-Year CAGR
(5.62%)
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| HKD 315M |
| N/A |
| N/A |
| N/A |
| Energy | HKD 94M | HKD 98M | HKD 106M | HKD 116M | HKD 124M | HKD 140M |
|---|
| Financial Risk Compliance Advisory | HKD 156M | HKD 135M | HKD 124M | N/A | N/A | N/A |
|---|
| Financial Services Advisory And Compliance | N/A | N/A | N/A | HKD 152M | HKD 140M | HKD 144M |
|---|
| Health Care | N/A | N/A | N/A | N/A | N/A | HKD 389M |
|---|
| Healthcare | HKD 183M | HKD 224M | HKD 289M | HKD 354M | HKD 370M | N/A |
|---|
| UNITED STATES |
|---|
| HKD 932M |
| HKD 681M |
| HKD 17M |
| HKD 171M |
| HKD 46M |
